Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Video summary

Metformin and rapamycin for aging: mouse promise, unknown effects in healthy people

Dr. Steven Austad says metformin and rapamycin show promise in mice, but their effects on healthy people remain unknown; over 20 clinical trials are underway, and he advises against self-medicating. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Austad says metformin and rapamycin show promise in mice, but their effects on healthy people remain unknown. [1]

  2. More than 20 clinical trials are currently underway to evaluate senolytics and other compounds. [1]

  3. Austad advises against self-medicating because the supplement industry is unregulated. [1]

The source at a glance

Study type / format
Video description of an expert discussion
Population / context
Healthy people and mice, as discussed in the description
Summary based on
Creator description
Original publication
September 25, 2026

Austad on mouse promise and unknown human effects

In the description, Dr. Steven Austad discusses research into drugs such as metformin and rapamycin for slowing aging. He notes that these drugs show promise in mice, but that their effects on healthy people remain unknown. The description does not report results from any human trial of these drugs.

Supporting source [1]

Over 20 trials of senolytics and other compounds

According to the description, more than 20 clinical trials are currently underway to evaluate senolytics and other compounds. The description gives no results from these trials and does not name the compounds beyond metformin and rapamycin.

Supporting source [1]

Austad's warning against self-medicating

The description says Austad advises against self-medicating because the supplement industry is unregulated. This is a caution about unregulated products, not a report of trial findings. The description does not state doses or schedules.

Supporting source [1]

How to interpret this

This is based only on the video description; the video and transcript were not reviewed. The description reports no trial results, sample sizes, follow-up or outcome data.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Metformin, rapamycin for slowing of aging. 20 senolytics are in clinical trials. Results?

Diagnostic Detectives Network · youtube.com · September 25, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    their effects on healthy people remain unknown
  2. Finding 2 ↑

    over 20 clinical trials are currently underway
  3. Finding 3 ↑

    advises against self-medicating due to the unregulated

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…